Overview

Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin Analogs

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the variations in pharmacokinetic and pharmacodynamic properties of rapid-acting insulin analogs when given as a bolus by subcutaneous insulin infusion pump as typically encountered in the care of children with type 1 diabetes. The specific factors under investigation are: - the effects of puberty - type of insulin analog - site of catheter insertion - and age of catheter
Phase:
Phase 1
Details
Lead Sponsor:
Yale University
Treatments:
Insulin
Insulin Aspart
Insulin degludec, insulin aspart drug combination
Insulin Detemir
Insulin Glargine
Insulin Lispro
Insulin, Globin Zinc
Insulin, Long-Acting
Insulin, Short-Acting